{"id":15884,"date":"2021-12-14T13:13:36","date_gmt":"2021-12-14T13:13:36","guid":{"rendered":"https:\/\/incilab.az\/molekulyar-testl%c9%99r-qrupu\/"},"modified":"2023-09-14T09:14:43","modified_gmt":"2023-09-14T09:14:43","slug":"molecular-tests-group","status":"publish","type":"page","link":"https:\/\/incilab.az\/en\/molecular-tests-group\/","title":{"rendered":"Molecular tests group"},"content":{"rendered":"

[vc_row][vc_column]

\r\n \r\n <\/div>\r\n
<\/div>
\r\n

APOL\u0130POPROTE\u0130N E GENOT\u0130PL\u018fND\u0130RM\u018fS\u0130<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0B\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>5 mL<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0PZR<\/p>\n

Referens:\u00a0<\/strong>\u00a0Normal genotip e3\/e3<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Apo E genotipl\u0259ri III tip hi\u00adper\u00adlipoproteinemiya v\u0259 erk\u0259n koronar \u00fcr\u0259k x\u0259st\u0259liyinin inki\u015faf\u0131 il\u0259 \u0259laq\u0259\u00addar\u00add\u0131r. H\u0259m\u00e7inin e4 allelinin varl\u0131\u011f\u0131 Alzheimer x\u0259s\u0259liyi \u00fc\u00e7\u00fcn \u0259h\u0259miyy\u0259tli risk faktorudur<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

CHLAMYDIA TRACHOMATIS (PZR)<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Sidiyin plastik qaba g\u00f6t\u00fcr\u00fclm\u00fc\u015f ilk porsiyas\u0131 v\u0259 ya x\u00fcsusi tamponla (qad\u0131nlarda servikal, ki\u015fi\u00adl\u0259rd\u0259 uretral) s\u0131yr\u0131nt\u0131<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Laz\u0131m olan l\u0259va\u00adzi\u00admatlar laboratoriya t\u0259r\u0259find\u0259n t\u0259min edilir<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0Sidik, ilk porsiya 15 mL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:<\/strong>\u00a0N\u00fc\u00admu\u00adn\u0259 g\u00f6t\u00fcr\u00fcld\u00fckd\u0259n sonra soyuq \u015f\u0259raitd\u0259 saxlan\u0131lmal\u0131 v\u0259 vaxt itirm\u0259\u00add\u0259n, soyuq \u015f\u0259raitd\u0259 laboratoriyaya \u00e7atd\u0131r\u0131lmal\u0131d\u0131r<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>N\u00fc\u00admun\u0259nin uzun m\u00fcdd\u0259t otaq tempe\u00adraturunda saxlan\u0131lmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0Chlamydia trachomatis\u00a0<\/em>infeksiyas\u0131n\u0131n t\u0259yinind\u0259 PZR \u00fcsulu kultural v\u0259 seroloji \u00fcsullarla m\u00fcqa\u00adyis\u0259d\u0259 daha h\u0259ssasd\u0131r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

CMV PZR<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum, EDTA-l\u0131 tam qan, BOM<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (serum), b\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (EDTA-l\u0131 tam qan), gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si (BOM)<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a01 mL<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0PZR\/DNT hibridizasiya<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0H\u0259ddind\u0259n art\u0131q hemoliz, lipemiya, sar\u0131l\u0131q<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>CMV infeksiyas\u0131n\u0131n t\u0259yinind\u0259 istifad\u0259 olunur<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

COXSACK\u0130E A V\u018f B (ENTEROV\u0130RUS PZR)<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>BOM<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a02 mL<\/p>\n

Testin t\u0259rkibi:\u00a0<\/strong>Coxsackie A v\u0259 B, ECHO-virus, poliovirus, enterovirus 68-71 v\u0259 s. b\u00fct\u00fcn enteroviruslar<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0RT-PZR<\/p>\n

Referens:\u00a0<\/strong>N\u0259tic\u0259d\u0259 bildirilir<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Enteroviruslar, Picorna\u00advi\u00adri\u00addae f\u0259sil\u0259sin\u0259 m\u0259xsusdurlar v\u0259 70-d\u0259n \u00e7ox serotipi (Coxsackie A v\u0259 B, ECHO-virus, poliovirus, ente\u00adrovirus 68-71 v\u0259 s.) var. Bunlar\u0131n \u00e7oxu fekal-oral yolla yoluxsa da, yuxar\u0131 t\u0259n\u0259ff\u00fcs yollar\u0131 il\u0259 d\u0259 yo\u00adlux\u00adma m\u00fcmk\u00fcnd\u00fcr. Non-polio entero\u00adviruslar ad\u0259t\u0259n yuxar\u0131 t\u0259n\u0259ff\u00fcs yol\u00adlar\u0131 infeksiyalar\u0131 v\u0259 s\u0259pkil\u0259rl\u0259 ya\u00adna\u015f\u0131, aseptik meningit v\u0259 ensefalit\u0259 d\u0259 s\u0259b\u0259b ola bil\u0259rl\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

DNT EKSTRAKS\u0130YASI<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>DNT izolyasiyas\u0131; DNT-nin ay\u0131rd edilm\u0259si<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:<\/strong>\u00a0EDTA-l\u0131 tam qan, toxuma, d\u00f6l material\u0131 [g\u00f6b\u0259k ciy\u0259si qan\u0131, korion villus (CVS) v\u0259 ya am\u00adnion mayesi (AFS) ], kultura ma\u00adterial\u0131<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0B\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (qan mareriallar\u0131 \u00fc\u00e7\u00fcn); toxuma, CVS v\u0259 AFS kimi mate\u00adriallar \u00fc\u00e7\u00fcn bunlar\u0131 alan h\u0259kimin se\u00e7diyi m\u00fcnasib qab g\u00f6t\u00fcr\u00fcl\u00fcr<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0EDTA-l\u0131 tam qan 5 mL, toxuma (10 mg), d\u00f6l mate\u00adri\u00adyal\u0131, AFS (10 mg ),\u00a0 g\u00f6b\u0259k ciy\u0259si qan\u0131 (500 \u03bcL)<\/p>\n

Laz\u0131mi m\u0259lumatlar:\u00a0<\/strong>X\u0259st\u0259 haq\u00adq\u0131n\u00adda klinik m\u0259lumatlar g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0Kit v\u0259 ya NaCl ekst\u00adraksiyas\u0131 v\u0259 spektrofotometrik qiym\u0259tl\u0259ndirm\u0259<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri (kan):\u00a0<\/strong>H\u00fcceyr\u0259 say\u0131n\u0131n az olmas\u0131, hemoliz, laxta, material\u0131n uy\u011fun ol\u00admayan s\u0131naq \u015f\u00fc\u015f\u0259sind\u0259 g\u00f6n\u0259rilm\u0259si<\/p>\n

Referens:\u00a0<\/strong>O.D A260<\/sub>\u00a0\/A280 =<\/sub>1.6-1.8<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Genetik x\u0259st\u0259likl\u0259rin molekulyar diaqnozunda istifad\u0259 olunan DNT material\u0131n\u0131n \u0259ld\u0259 olunmas\u0131 m\u0259qs\u0259dil\u0259 t\u0259tbiq edilir. M\u00f6vcud fakt v\u0259 ya ail\u0259y\u0259 aid mutasiya analizi\/da\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131n\u0131n t\u0259yi\u00adnind\u0259 DNT ekstraksiyas\u0131, EDTA-l\u0131 tam qan v\u0259 ya toxuma material\u0131 il\u0259 apar\u0131l\u0131r. Prenatal diaqnostika \u00fc\u00e7\u00fcn is\u0259 CVS, AFS v\u0259 g\u00f6b\u0259k ciy\u0259si qan\u0131 laz\u0131md\u0131r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

DNT \u0130ZOLYAS\u0130YASI<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>DNT izolyasiyas\u0131; DNT-nin ay\u0131rd edilm\u0259si<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:<\/strong>\u00a0EDTA-l\u0131 tam qan, toxuma, d\u00f6l material\u0131 [g\u00f6b\u0259k ciy\u0259si qan\u0131, korion villus (CVS) v\u0259 ya am\u00adnion mayesi (AFS) ], kultura ma\u00adterial\u0131<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0B\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (qan mareriallar\u0131 \u00fc\u00e7\u00fcn); toxuma, CVS v\u0259 AFS kimi mate\u00adriallar \u00fc\u00e7\u00fcn bunlar\u0131 alan h\u0259kimin se\u00e7diyi m\u00fcnasib qab g\u00f6t\u00fcr\u00fcl\u00fcr<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0EDTA-l\u0131 tam qan 5 mL, toxuma (10 mg), d\u00f6l mate\u00adri\u00adyal\u0131, AFS (10 mg ),\u00a0 g\u00f6b\u0259k ciy\u0259si qan\u0131 (500 \u03bcL)<\/p>\n

Laz\u0131mi m\u0259lumatlar:\u00a0<\/strong>X\u0259st\u0259 haq\u00adq\u0131n\u00adda klinik m\u0259lumatlar g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0Kit v\u0259 ya NaCl ekst\u00adraksiyas\u0131 v\u0259 spektrofotometrik qiym\u0259tl\u0259ndirm\u0259<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri (kan):\u00a0<\/strong>H\u00fcceyr\u0259 say\u0131n\u0131n az olmas\u0131, hemoliz, laxta, material\u0131n uy\u011fun ol\u00admayan s\u0131naq \u015f\u00fc\u015f\u0259sind\u0259 g\u00f6n\u0259rilm\u0259si<\/p>\n

Referens:\u00a0<\/strong>O.D A260<\/sub>\u00a0\/A280 =<\/sub>1.6-1.8<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Genetik x\u0259st\u0259likl\u0259rin molekulyar diaqnozunda istifad\u0259 olunan DNT material\u0131n\u0131n \u0259ld\u0259 olunmas\u0131 m\u0259qs\u0259dil\u0259 t\u0259tbiq edilir. M\u00f6vcud fakt v\u0259 ya ail\u0259y\u0259 aid mutasiya analizi\/da\u015f\u0131y\u0131c\u0131l\u0131\u011f\u0131n\u0131n t\u0259yi\u00adnind\u0259 DNT ekstraksiyas\u0131, EDTA-l\u0131 tam qan v\u0259 ya toxuma material\u0131 il\u0259 apar\u0131l\u0131r. Prenatal diaqnostika \u00fc\u00e7\u00fcn is\u0259 CVS, AFS v\u0259 g\u00f6b\u0259k ciy\u0259si qan\u0131 laz\u0131md\u0131r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

DNT KONTENT ANAL\u0130Z\u0130<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Parfinli v\u0259 t\u0259z\u0259 to\u00adxuma n\u00fcmun\u0259l\u0259ri, orqanizim ma\u00adye\u00adl\u0259ri, sidik kis\u0259si lavaj mayesi, sidik, sitratl\u0131 tam qan, s\u00fcm\u00fck iliyi<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Mavi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (sitratl\u0131 qan)<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a02mL<\/p>\n

Laz\u0131mi m\u0259lumatlar:<\/strong>\u00a0X\u0259st\u0259 haq\u00adq\u0131n\u00adda klinik m\u0259lumat g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0Flow cytometry<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0H\u00fcceyr\u0259 say\u0131n\u0131n az olmas\u0131<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>B\u0259rk toxuma (solid) \u015fi\u015f\u00adl\u0259ri v\u0259 neoplazik lezyonlarda h\u00fccey\u00adr\u0259daxili DNT kontent analizi v\u0259 proliferasiya s\u00fcr\u0259tinin t\u0259yinind\u0259 istifad\u0259 olunur. Bu test il\u0259 statistik v\u0259 dinamik proliferasiya indeksinin m\u00fc\u00ad\u0259yy\u0259nl\u0259\u015fdirilm\u0259si, h\u00fcceyr\u0259 ane\u00aduoplo\u00adidiyas\u0131n\u0131n v\u0259 \u015fi\u015fl\u0259rin \u00e7oxalma tezliyinin t\u0259yini m\u00fcmk\u00fcnd\u00fcr<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

ECHOV\u0130RUS (ENTEROV\u0130RUS PZR)<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>BOM<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a02 mL<\/p>\n

Testin t\u0259rkibi:\u00a0<\/strong>Coxsackie A v\u0259 B, ECHO-virus, poliovirus, enterovirus 68-71 v\u0259 s. b\u00fct\u00fcn enteroviruslar<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0RT-PZR<\/p>\n

Referens:\u00a0<\/strong>N\u0259tic\u0259d\u0259 bildirilir<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Enteroviruslar, Picorna\u00advi\u00adri\u00addae f\u0259sil\u0259sin\u0259 m\u0259xsusdurlar v\u0259 70-d\u0259n \u00e7ox serotipi (Coxsackie A v\u0259 B, ECHO-virus, poliovirus, ente\u00adrovirus 68-71 v\u0259 s.) var. Bunlar\u0131n \u00e7oxu fekal-oral yolla yoluxsa da, yuxar\u0131 t\u0259n\u0259ff\u00fcs yollar\u0131 il\u0259 d\u0259 yo\u00adlux\u00adma m\u00fcmk\u00fcnd\u00fcr. Non-polio entero\u00adviruslar ad\u0259t\u0259n yuxar\u0131 t\u0259n\u0259ff\u00fcs yol\u00adlar\u0131 infeksiyalar\u0131 v\u0259 s\u0259pkil\u0259rl\u0259 ya\u00adna\u015f\u0131, aseptik meningit v\u0259 ensefalit\u0259 d\u0259 s\u0259b\u0259b ola bil\u0259rl\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

ENTEROV\u0130RUS PZR<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>BOM<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a02 mL<\/p>\n

Testin t\u0259rkibi:\u00a0<\/strong>Coxsackie A v\u0259 B, ECHO-virus, poliovirus, enterovirus 68-71 v\u0259 s. b\u00fct\u00fcn enteroviruslar<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0RT-PZR<\/p>\n

Referens:\u00a0<\/strong>N\u0259tic\u0259d\u0259 bildirilir<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Enteroviruslar, Picorna\u00advi\u00adri\u00addae f\u0259sil\u0259sin\u0259 m\u0259xsusdurlar v\u0259 70-d\u0259n \u00e7ox serotipi (Coxsackie A v\u0259 B, ECHO-virus, poliovirus, ente\u00adrovirus 68-71 v\u0259 s.) var. Bunlar\u0131n \u00e7oxu fekal-oral yolla yoluxsa da, yuxar\u0131 t\u0259n\u0259ff\u00fcs yollar\u0131 il\u0259 d\u0259 yo\u00adlux\u00adma m\u00fcmk\u00fcnd\u00fcr. Non-polio entero\u00adviruslar ad\u0259t\u0259n yuxar\u0131 t\u0259n\u0259ff\u00fcs yol\u00adlar\u0131 infeksiyalar\u0131 v\u0259 s\u0259pkil\u0259rl\u0259 ya\u00adna\u015f\u0131, aseptik meningit v\u0259 ensefalit\u0259 d\u0259 s\u0259b\u0259b ola bil\u0259rl\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HBV DNT (PZR)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit B DNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131 :\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admolizli, EDTA-l\u0131 v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcd\u00add\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>HBV infeksiyalar\u0131n\u0131n er\u00adk\u0259n d\u00f6vrl\u0259rind\u0259 ancisim s\u0259viyy\u0259si a\u015fa\u00ad\u011f\u0131 oldu\u011fundan seroloji testl\u0259r ye\u00adt\u0259rsizdir. Bu s\u0259b\u0259bd\u0259n virusun bir\u00adba\u015fa t\u0259yinin\u0259 imkan ver\u0259n h\u0259ssas v\u0259 spesifik PZR \u00fcsulu istifad\u0259 olunur. Asimptomatik da\u015f\u0131y\u0131c\u0131lar, anticisim \u0259m\u0259l\u0259 g\u0259l\u0259n\u0259 q\u0259d\u0259rki m\u0259rh\u0259l\u0259, sero\u00adpozitiv analardan do\u011fulan u\u015faqlar, immunoloji reaksiya verm\u0259y\u0259n x\u0259s\u00adt\u0259l\u0259r, h\u0259m\u00e7inin seroloji testl\u0259ri po\u00adzi\u00adtiv olan x\u0259st\u0259l\u0259rd\u0259 diaq\u00adnozun d\u0259qiq\u00adl\u0259\u015fdirilm\u0259si v\u0259 m\u00fcalic\u0259nin m\u00fc\u015fa\u00adhi\u00add\u0259si \u00fc\u00e7\u00fcn HBV DNT istifad\u0259 oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HBV PZR (Virus Y\u00fck\u00fc)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit B virus y\u00fck\u00fc<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>300 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>He\u00admolizli v\u0259 ya uy\u011fun olmayan s\u0131naq \u015f\u00fc\u015f\u0259sind\u0259 g\u00f6nd\u0259ril\u0259n n\u00fcmun\u0259l\u0259r; n\u00fc\u00admun\u0259nin uzun m\u00fcdd\u0259t otaq tem\u00adperaturunda qalmas\u0131<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Serumdak\u0131 HBV miq\u00adda\u00adr\u0131n\u0131 t\u0259yin em\u0259k \u00fc\u00e7\u00fcn istifad\u0259 olunur. Klinik v\u0259 dig\u0259r laborator n\u0259tic\u0259l\u0259r il\u0259 birlikd\u0259 x\u0259st\u0259liyin proqnozunun t\u0259\u00adyini v\u0259 m\u00fcalic\u0259nin m\u00fc\u015fahid\u0259sind\u0259 istifad\u0259 olunur<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HCV GENOT\u0130P T\u018fY\u0130N\u0130<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit C genotip t\u0259yini<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0DNT sekvenl\u0259\u015fdirm\u0259 analizi (DNA sequencing analysis)<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admolizli v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcdd\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>HCV tip t\u0259yini x\u0259st\u0259liyin gedi\u015fi v\u0259 m\u00fcalic\u0259si \u00fc\u00e7\u00fcn \u0259h\u0259\u00admiy\u00ady\u0259t\u00adlidir. T\u0259yin olunan genotip v\u0259 alt tipl\u0259r bunlard\u0131r: 1a,1b,1c,2a\/c,2b, 3a, 3b,3c,4a,4b,4c\/d,4e,4f,4h,5a,6a<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HCV RNT<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit C RNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0RT-PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admolizli v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcdd\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>HCV infeksiyalar\u0131n\u0131n er\u00adk\u0259n d\u00f6vrl\u0259rind\u0259 ancisim s\u0259viyy\u0259si a\u015fa\u011f\u0131 oldu\u011fundan seroloji testl\u0259r kifay\u0259t etmir. Bundan ba\u015fqa, HCV il\u0259 yoluxma zaman\u0131 antisimin varl\u0131\u011f\u0131 he\u00e7 d\u0259 h\u0259mi\u015f\u0259 viremiya il\u0259 birlikd\u0259 m\u00fc\u015fahid\u0259 olunmur. Buna g\u00f6r\u0259 d\u0259 virusun birba\u015fa t\u0259yinin\u0259 imkan ver\u0259n, h\u0259ssas v\u0259 spesifik \u00fcsul olan PZR istifad\u0259 olunur. Asimptomatik da\u015f\u0131y\u0131c\u0131lar, anticisim h\u0259l\u0259 \u0259m\u0259l\u0259 g\u0259l\u00adm\u0259y\u0259n hallar, seropozitiv analardan do\u011fulan u\u015faqlar, immunoloji reak\u00adsiya verm\u0259y\u0259n x\u0259st\u0259l\u0259r v\u0259 seroloji testl\u0259ri pozitiv olan x\u0259st\u0259l\u0259rd\u0259 diaq\u00adnozun d\u0259qiql\u0259\u015fdirilm\u0259si v\u0259 m\u00fcali\u00adc\u0259nin m\u00fc\u015fahid\u0259si \u00fc\u00e7\u00fcn HCV RNT istifad\u0259 oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HCV V\u0130RUS Y\u00dcK\u00dc<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatir C virus y\u00fck\u00fc<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>500\u00a0 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fcmun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>RT-PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0Hemolizli v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcdd\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Bu testl\u0259 serum v\u0259 ya plazmadak\u0131 HCV RNT miqdar\u0131 t\u0259yin edilir. Klinik v\u0259 dig\u0259r laborator n\u0259tic\u0259l\u0259r il\u0259 birlikd\u0259 x\u0259st\u0259liyin proqnozunun t\u0259yini v\u0259 m\u00fcalic\u0259nin m\u00fc\u015fahid\u0259sind\u0259 istifad\u0259 olunur<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HDV RNT<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit D RNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500\u00a0 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlan\u0131lmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>RT-PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>He\u00admo\u00adlizli v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r; n\u00fc\u00admun\u0259nin uzun m\u00fcdd\u0259t otaq tem\u00adperaturunda saxlan\u0131lmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>HDV infeksiyas\u0131n\u0131n diaq\u00adnozu serumda anti-HDV antici\u00adsim\u00adl\u0259\u00adri v\u0259 ya delta antigeninin (HDV Ag) t\u0259yini il\u0259 m\u00fc\u0259yy\u0259n olunur. Delta an\u00adtigeninin s\u0259viyy\u0259si k\u0259skin infeksiya m\u00fcdd\u0259tind\u0259 d\u0259yi\u015fk\u0259n olur. Xroniki in\u00adfeksiyalarda is\u0259 nadir hallarda del\u00adta antigeni tap\u0131la bil\u0259r. H\u0259m\u00e7inin an\u00adti-HDV tap\u0131lmas\u0131 he\u00e7 d\u0259 h\u0259mi\u015f\u0259 ak\u00adtiv HDV infeksiyas\u0131n\u0131n g\u00f6st\u0259ricisi de\u00ad\u00adyildir. Bu bax\u0131mdan aktiv HDV in\u00adfek\u00adsiyas\u0131n\u0131 m\u00fc\u0259yy\u0259n etm\u0259k\u00a0 \u00fc\u00e7\u00fcn PZR il\u0259 HDV RNT t\u0259dqiq oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HEPAT\u0130T B V\u0130RUS Y\u00dcK\u00dc (HBV PZR)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit B virus y\u00fck\u00fc<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>300 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>He\u00admolizli v\u0259 ya uy\u011fun olmayan s\u0131naq \u015f\u00fc\u015f\u0259sind\u0259 g\u00f6nd\u0259ril\u0259n n\u00fcmun\u0259l\u0259r; n\u00fc\u00admun\u0259nin uzun m\u00fcdd\u0259t otaq tem\u00adperaturunda qalmas\u0131<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Serumdak\u0131 HBV miq\u00adda\u00adr\u0131n\u0131 t\u0259yin em\u0259k \u00fc\u00e7\u00fcn istifad\u0259 olunur. Klinik v\u0259 dig\u0259r laborator n\u0259tic\u0259l\u0259r il\u0259 birlikd\u0259 x\u0259st\u0259liyin proqnozunun t\u0259\u00adyini v\u0259 m\u00fcalic\u0259nin m\u00fc\u015fahid\u0259sind\u0259 istifad\u0259 olunur<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HEPAT\u0130T C GENOT\u0130P T\u018fY\u0130N\u0130 (HCV GENOT\u0130P T\u018fY\u0130N\u0130)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit C genotip t\u0259yini<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0DNT sekvenl\u0259\u015fdirm\u0259 analizi (DNA sequencing analysis)<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admolizli v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcdd\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>HCV tip t\u0259yini x\u0259st\u0259liyin gedi\u015fi v\u0259 m\u00fcalic\u0259si \u00fc\u00e7\u00fcn \u0259h\u0259\u00admiy\u00ady\u0259t\u00adlidir. T\u0259yin olunan genotip v\u0259 alt tipl\u0259r bunlard\u0131r: 1a,1b,1c,2a\/c,2b, 3a, 3b,3c,4a,4b,4c\/d,4e,4f,4h,5a,6a<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HEPAT\u0130T C RNT (HCV RNT)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit C RNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0RT-PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admolizli v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcdd\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>HCV infeksiyalar\u0131n\u0131n er\u00adk\u0259n d\u00f6vrl\u0259rind\u0259 ancisim s\u0259viyy\u0259si a\u015fa\u011f\u0131 oldu\u011fundan seroloji testl\u0259r kifay\u0259t etmir. Bundan ba\u015fqa, HCV il\u0259 yoluxma zaman\u0131 antisimin varl\u0131\u011f\u0131 he\u00e7 d\u0259 h\u0259mi\u015f\u0259 viremiya il\u0259 birlikd\u0259 m\u00fc\u015fahid\u0259 olunmur. Buna g\u00f6r\u0259 d\u0259 virusun birba\u015fa t\u0259yinin\u0259 imkan ver\u0259n, h\u0259ssas v\u0259 spesifik \u00fcsul olan PZR istifad\u0259 olunur. Asimptomatik da\u015f\u0131y\u0131c\u0131lar, anticisim h\u0259l\u0259 \u0259m\u0259l\u0259 g\u0259l\u00adm\u0259y\u0259n hallar, seropozitiv analardan do\u011fulan u\u015faqlar, immunoloji reak\u00adsiya verm\u0259y\u0259n x\u0259st\u0259l\u0259r v\u0259 seroloji testl\u0259ri pozitiv olan x\u0259st\u0259l\u0259rd\u0259 diaq\u00adnozun d\u0259qiql\u0259\u015fdirilm\u0259si v\u0259 m\u00fcali\u00adc\u0259nin m\u00fc\u015fahid\u0259si \u00fc\u00e7\u00fcn HCV RNT istifad\u0259 oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HEPAT\u0130T C V\u0130RUS Y\u00dcK\u00dc (HCV V\u0130RUS Y\u00dcK\u00dc)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatir C virus y\u00fck\u00fc<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>500\u00a0 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fcmun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>RT-PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0Hemolizli v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcdd\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Bu testl\u0259 serum v\u0259 ya plazmadak\u0131 HCV RNT miqdar\u0131 t\u0259yin edilir. Klinik v\u0259 dig\u0259r laborator n\u0259tic\u0259l\u0259r il\u0259 birlikd\u0259 x\u0259st\u0259liyin proqnozunun t\u0259yini v\u0259 m\u00fcalic\u0259nin m\u00fc\u015fahid\u0259sind\u0259 istifad\u0259 olunur<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HEPAT\u0130T D RNT (HDV RNT)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit D RNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131\u00adnaq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500\u00a0 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlan\u0131lmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>RT-PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>He\u00admo\u00adlizli v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r; n\u00fc\u00admun\u0259nin uzun m\u00fcdd\u0259t otaq tem\u00adperaturunda saxlan\u0131lmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>HDV infeksiyas\u0131n\u0131n diaq\u00adnozu serumda anti-HDV antici\u00adsim\u00adl\u0259\u00adri v\u0259 ya delta antigeninin (HDV Ag) t\u0259yini il\u0259 m\u00fc\u0259yy\u0259n olunur. Delta an\u00adtigeninin s\u0259viyy\u0259si k\u0259skin infeksiya m\u00fcdd\u0259tind\u0259 d\u0259yi\u015fk\u0259n olur. Xroniki in\u00adfeksiyalarda is\u0259 nadir hallarda del\u00adta antigeni tap\u0131la bil\u0259r. H\u0259m\u00e7inin an\u00adti-HDV tap\u0131lmas\u0131 he\u00e7 d\u0259 h\u0259mi\u015f\u0259 ak\u00adtiv HDV infeksiyas\u0131n\u0131n g\u00f6st\u0259ricisi de\u00ad\u00adyildir. Bu bax\u0131mdan aktiv HDV in\u00adfek\u00adsiyas\u0131n\u0131 m\u00fc\u0259yy\u0259n etm\u0259k\u00a0 \u00fc\u00e7\u00fcn PZR il\u0259 HDV RNT t\u0259dqiq oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HERPES S\u0130MPLEKS PZR (HSV PZR)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:<\/strong>\u00a0Herpes simplex PZR<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>\u00a0BOM, a\u011f\u0131z \u0259traf\u0131 v\u0259 ya genital leziyondan tamponla al\u0131n\u00adm\u0131\u015f material<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si (BOM), gelsiz quru s\u0131naq \u015f\u00fc\u015f\u0259si (tampon materiallar\u0131)<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>1mL<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>PZR<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0\u015e\u00fcbh\u0259li d\u0259ri lezyonlar\u0131 olan v\u0259 ya virus ensefaliti yaxud me\u00adnengiti olan x\u0259st\u0259l\u0259rd\u0259 HSV-nin t\u0259\u00adyinind\u0259 is\u00adti\u00adfad\u0259 olunur. N\u0259tic\u0259 po\u00adzi\u00adtiv \u00e7\u0131xan hal\u00adlarda laz\u0131m g\u0259l\u0259rs\u0259.\u00a0 1-ci v\u0259 2-ci tipin differensiasiyas\u0131 apa\u00adr\u0131l\u0131r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HIV-1 PROV\u0130RUS DNT-si<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Human immunodeficiency virus provial DNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>EDTA-l\u0131 tam qan<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0B\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>3 mL<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>He\u00admo\u00adlizli v\u0259 heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fc\u00admun\u0259l\u0259rin uzun m\u00fcdd\u0259t otaq tem\u00adperaturunda saxlan\u0131lmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0ELISA v\u0259 Western blot kimi seroloji testl\u0259rl\u0259 HIV-\u0259 qar\u015f\u0131 \u0259m\u0259l\u0259 g\u0259l\u0259n anticisiml\u0259r t\u0259yin olun\u00addu\u011fundan bu tetl\u0259rin serokonver\u00adsi\u00adyadan \u0259vv\u0259lki d\u0259y\u0259rl\u0259ri m\u0259hduddur. PZR il\u0259 HIV-1-in birba\u015fa t\u0259yin olun\u00admas\u0131 m\u00fcmk\u00fcn olur. Yenido\u011fu\u00adlan\u00adlar\u00adda v\u0259 y\u00fcks\u0259k riskli x\u0259st\u0259l\u0259rd\u0259 erk\u0259n diaq\u00adnoz v\u0259 t\u0259sdiql\u0259m\u0259 m\u0259qs\u0259dil\u0259 HIV-1 provirus DNT testi istifad\u0259 oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HIV-1 RNT<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:<\/strong>HIV-1 virus y\u00fck\u00fc; Hu\u00adman immunodeficiency virus RNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>EDTA-l\u0131 tam qan<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0B\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (EDTA-l\u0131 plazma), mavi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (sitratl\u0131 plazma)<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlan\u0131lmal\u0131 v\u0259 g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0RT-PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admolizli v\u0259 heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259l\u0259rin uzun m\u00fcdd\u0259t otaq temperaturunda saxlan\u0131lmas\u0131<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0Plazmadak\u0131 HIV-1 RNT-nin\u00a0 miqdar\u0131n\u0131 t\u0259yin etm\u0259k \u00fc\u00e7\u00fcn isti\u00adfad\u0259 olunan testdir. Klinik \u0259lam\u0259tl\u0259r v\u0259 dig\u0259r laborator n\u0259tic\u0259l\u0259rl\u0259 birlikd\u0259 proqnozun t\u0259yini v\u0259 m\u00fcalic\u0259nin m\u00fc\u00ad\u015fahid\u0259sind\u0259 istifad\u0259 olunur<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HIV-1 V\u0130RUS Y\u00dcK\u00dc (HIV-1 RNT)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:<\/strong>HIV-1 virus y\u00fck\u00fc; Hu\u00adman immunodeficiency virus RNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>EDTA-l\u0131 tam qan<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0B\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (EDTA-l\u0131 plazma), mavi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si (sitratl\u0131 plazma)<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlan\u0131lmal\u0131 v\u0259 g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0RT-PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admolizli v\u0259 heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259l\u0259rin uzun m\u00fcdd\u0259t otaq temperaturunda saxlan\u0131lmas\u0131<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0Plazmadak\u0131 HIV-1 RNT-nin\u00a0 miqdar\u0131n\u0131 t\u0259yin etm\u0259k \u00fc\u00e7\u00fcn isti\u00adfad\u0259 olunan testdir. Klinik \u0259lam\u0259tl\u0259r v\u0259 dig\u0259r laborator n\u0259tic\u0259l\u0259rl\u0259 birlikd\u0259 proqnozun t\u0259yini v\u0259 m\u00fcalic\u0259nin m\u00fc\u00ad\u015fahid\u0259sind\u0259 istifad\u0259 olunur<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HPV PZR v\u0259 GENOT\u0130P T\u018fY\u0130N\u0130<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Human papilloma virus<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>\u00a0\u015e\u00fcbh\u0259li lezyondan tam\u00adponla al\u0131nm\u0131\u015f material (quru v\u0259\u00adziyy\u0259td\u0259) v\u0259 ya biopsiya material\u0131 (ste\u00ad\u00adril qabda, fizioloji m\u0259hlul i\u015f\u0259ri\u00adsind\u0259, soyuq \u015f\u0259raitd\u0259 g\u00f6nd\u0259ril\u00adm\u0259\u00adlidir)<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>PZR v\u0259 hibridizasiya<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>N\u00fc\u00admun\u0259nin qanla kontaminasiyas\u0131 v\u0259 uzun m\u00fcdd\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:<\/strong>\u00a0Neqativ<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0Servikal x\u0259r\u00e7\u0259ngl\u0259r, ser\u00advi\u00adkal intraepitelial neoplaziyalar (CN) v\u0259\u00a0Condylomata acuminata<\/em>\u00a0zaman\u0131 HPV-nin t\u0259yin olunmas\u0131nda istifad\u0259 olunur. Ehtiyac olduqda tap\u0131lm\u0131\u015f virusun tipi d\u0259 t\u0259yin oluna bil\u0259r. HPV 6, 11, 16, 18, 31, 33 v\u0259 35 tipl\u0259ri t\u0259yin oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HSV PZR<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:<\/strong>\u00a0Herpes simplex PZR<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>\u00a0BOM, a\u011f\u0131z \u0259traf\u0131 v\u0259 ya genital leziyondan tamponla al\u0131n\u00adm\u0131\u015f material<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si (BOM), gelsiz quru s\u0131naq \u015f\u00fc\u015f\u0259si (tampon materiallar\u0131)<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>1mL<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>PZR<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0\u015e\u00fcbh\u0259li d\u0259ri lezyonlar\u0131 olan v\u0259 ya virus ensefaliti yaxud me\u00adnengiti olan x\u0259st\u0259l\u0259rd\u0259 HSV-nin t\u0259\u00adyinind\u0259 is\u00adti\u00adfad\u0259 olunur. N\u0259tic\u0259 po\u00adzi\u00adtiv \u00e7\u0131xan hal\u00adlarda laz\u0131m g\u0259l\u0259rs\u0259.\u00a0 1-ci v\u0259 2-ci tipin differensiasiyas\u0131 apa\u00adr\u0131l\u0131r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HUMAN PAPILLOMA V\u0130RUS (HPV PZR v\u0259 GENOT\u0130P T\u018fY\u0130N\u0130)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Human papilloma virus<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>\u00a0\u015e\u00fcbh\u0259li lezyondan tam\u00adponla al\u0131nm\u0131\u015f material (quru v\u0259\u00adziyy\u0259td\u0259) v\u0259 ya biopsiya material\u0131 (ste\u00ad\u00adril qabda, fizioloji m\u0259hlul i\u015f\u0259ri\u00adsind\u0259, soyuq \u015f\u0259raitd\u0259 g\u00f6nd\u0259ril\u00adm\u0259\u00adlidir)<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>PZR v\u0259 hibridizasiya<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:\u00a0<\/strong>N\u00fc\u00admun\u0259nin qanla kontaminasiyas\u0131 v\u0259 uzun m\u00fcdd\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:<\/strong>\u00a0Neqativ<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0Servikal x\u0259r\u00e7\u0259ngl\u0259r, ser\u00advi\u00adkal intraepitelial neoplaziyalar (CN) v\u0259\u00a0Condylomata acuminata<\/em>\u00a0zaman\u0131 HPV-nin t\u0259yin olunmas\u0131nda istifad\u0259 olunur. Ehtiyac olduqda tap\u0131lm\u0131\u015f virusun tipi d\u0259 t\u0259yin oluna bil\u0259r. HPV 6, 11, 16, 18, 31, 33 v\u0259 35 tipl\u0259ri t\u0259yin oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

PARVOV\u0130RUS B19 PZR<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum, plazma, BOM, amniotik maye, s\u00fcm\u00fck iliyi<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si, b\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si, gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a01 mL<\/p>\n

\u0130\u015f prinsipi:\u00a0<\/strong>PZR<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0D\u00f6ld\u0259 v\u0259 yenido\u011fulanda, h\u0259m\u00e7inin immun sistemi v\u0259 ya im\u00admun cavab\u0131 z\u0259ifl\u0259mi\u015f x\u0259st\u0259l\u0259rd\u0259 Par\u00advovirus B19 anticisiml\u0259ri diaqnostik bax\u0131mdan yet\u0259rli olmaya bil\u0259r. Bel\u0259 hallarda infeksiyan\u0131n diaqnozu \u00fc\u00e7\u00fcn Parvovirus B19 PZR il\u0259 DNT t\u0259yini m\u00fcmk\u00fcnd\u00fcr<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

POL\u0130OV\u0130RUS (ENTEROV\u0130RUS PZR)<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>BOM<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a02 mL<\/p>\n

Testin t\u0259rkibi:\u00a0<\/strong>Coxsackie A v\u0259 B, ECHO-virus, poliovirus, enterovirus 68-71 v\u0259 s. b\u00fct\u00fcn enteroviruslar<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0RT-PZR<\/p>\n

Referens:\u00a0<\/strong>N\u0259tic\u0259d\u0259 bildirilir<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>Enteroviruslar, Picorna\u00advi\u00adri\u00addae f\u0259sil\u0259sin\u0259 m\u0259xsusdurlar v\u0259 70-d\u0259n \u00e7ox serotipi (Coxsackie A v\u0259 B, ECHO-virus, poliovirus, ente\u00adrovirus 68-71 v\u0259 s.) var. Bunlar\u0131n \u00e7oxu fekal-oral yolla yoluxsa da, yuxar\u0131 t\u0259n\u0259ff\u00fcs yollar\u0131 il\u0259 d\u0259 yo\u00adlux\u00adma m\u00fcmk\u00fcnd\u00fcr. Non-polio entero\u00adviruslar ad\u0259t\u0259n yuxar\u0131 t\u0259n\u0259ff\u00fcs yol\u00adlar\u0131 infeksiyalar\u0131 v\u0259 s\u0259pkil\u0259rl\u0259 ya\u00adna\u015f\u0131, aseptik meningit v\u0259 ensefalit\u0259 d\u0259 s\u0259b\u0259b ola bil\u0259rl\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

TBC DNT (V\u018fR\u018fM\u0130N MOLEKULYAR D\u0130AQNOZU)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:<\/strong>\u00a0Tbc DNT; Tbc PCR; Gen-probe MTD<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>\u00a0B\u0259l\u011f\u0259m, bronxoal\u00adveolyar lavaj mayesi, m\u0259d\u0259 \u015fir\u0259si, sidik, BOM, plevra, perikard, assit v\u0259 oynaq mayesi kimi orqanizm mayel\u0259ri, toxuma n\u00fcmun\u0259l\u0259ri, abses (qan v\u0259 qanl\u0131 n\u00fcmun\u0259l\u0259r il\u0259 m\u00fcayin\u0259 apar\u0131lm\u0131r)<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Steril, bur\u011fulu qapaql\u0131 qab<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0B\u0259l\u011f\u0259m (10 mL), sidik (2 mL), orqanizm mayel\u0259ri (10-15 mL), BOM (2 mL)<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>Mycobacterium kulturas\u0131 \u00fc\u00e7\u00fcn t\u0259yin olunmu\u015f n\u00fcmun\u0259 alma qaydalar\u0131 q\u00fcvv\u0259d\u0259dir. Qanl\u0131 v\u0259 parafinli biopsiya n\u00fcmun\u0259sind\u0259n m\u00fcayin\u0259 \u00fc\u00e7\u00fcn istifad\u0259 etm\u0259k olmaz<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0Trasnscription Mediated Amplification (TMA)<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0N\u00fc\u00admun\u0259 miqdar\u0131n\u0131n yet\u0259rli olmamas\u0131, steril qabada al\u0131nmamas\u0131, b\u0259l\u011f\u0259m yerin\u0259 a\u011f\u0131z suyu verilm\u0259si, n\u00fcmu\u00adn\u0259nin qanl\u0131 olmas\u0131<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0N\u00fcmun\u0259d\u0259\u00a0M.Tuber\u00adculosis\u00a0<\/em>varl\u0131\u011f\u0131n\u0131 d\u0259qiql\u0259\u015fdirm\u0259k \u00fc\u00e7\u00fcn istifad\u0259 olunur. Bu \u00fcsulla, n\u00fc\u00admun\u0259d\u0259 1 v\u0259r\u0259m \u00e7\u00f6p\u00fc\/mL ol\u00adduqda bel\u0259 diaqnoz qoyula bilir. S\u00fcr\u0259tli diaq\u00adnoza imkan verm\u0259si \u00fcst\u00fcn c\u0259h\u0259tidir<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

TBC PZR (V\u018fR\u018fM\u0130N MOLEKULYAR D\u0130AQNOZU)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:<\/strong>\u00a0Tbc DNT; Tbc PCR; Gen-probe MTD<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>\u00a0B\u0259l\u011f\u0259m, bronxoal\u00adveolyar lavaj mayesi, m\u0259d\u0259 \u015fir\u0259si, sidik, BOM, plevra, perikard, assit v\u0259 oynaq mayesi kimi orqanizm mayel\u0259ri, toxuma n\u00fcmun\u0259l\u0259ri, abses (qan v\u0259 qanl\u0131 n\u00fcmun\u0259l\u0259r il\u0259 m\u00fcayin\u0259 apar\u0131lm\u0131r)<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Steril, bur\u011fulu qapaql\u0131 qab<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0B\u0259l\u011f\u0259m (10 mL), sidik (2 mL), orqanizm mayel\u0259ri (10-15 mL), BOM (2 mL)<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>Mycobacterium kulturas\u0131 \u00fc\u00e7\u00fcn t\u0259yin olunmu\u015f n\u00fcmun\u0259 alma qaydalar\u0131 q\u00fcvv\u0259d\u0259dir. Qanl\u0131 v\u0259 parafinli biopsiya n\u00fcmun\u0259sind\u0259n m\u00fcayin\u0259 \u00fc\u00e7\u00fcn istifad\u0259 etm\u0259k olmaz<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0Trasnscription Mediated Amplification (TMA)<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0N\u00fc\u00admun\u0259 miqdar\u0131n\u0131n yet\u0259rli olmamas\u0131, steril qabada al\u0131nmamas\u0131, b\u0259l\u011f\u0259m yerin\u0259 a\u011f\u0131z suyu verilm\u0259si, n\u00fcmu\u00adn\u0259nin qanl\u0131 olmas\u0131<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0N\u00fcmun\u0259d\u0259\u00a0M.Tuber\u00adculosis\u00a0<\/em>varl\u0131\u011f\u0131n\u0131 d\u0259qiql\u0259\u015fdirm\u0259k \u00fc\u00e7\u00fcn istifad\u0259 olunur. Bu \u00fcsulla, n\u00fc\u00admun\u0259d\u0259 1 v\u0259r\u0259m \u00e7\u00f6p\u00fc\/mL ol\u00adduqda bel\u0259 diaqnoz qoyula bilir. S\u00fcr\u0259tli diaq\u00adnoza imkan verm\u0259si \u00fcst\u00fcn c\u0259h\u0259tidir<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

TOKSOPLAZMA PZR<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Amnion mayesi v\u0259 ya BOM<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Gelsiz d\u00fcz s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a01 mL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:<\/strong>\u00a0N\u00fc\u00admun\u0259 al\u0131nd\u0131qdan sonra soyuq \u015f\u0259\u00adraitd\u0259 saxlan\u0131lmal\u0131 v\u0259 laboratoriyaya \u00e7atd\u0131r\u0131lmal\u0131d\u0131r<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0PZR\/DNT hibridizasiya<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admoliz\u0259 u\u011fram\u0131\u015f v\u0259 ya sentrifuqadan ke\u00e7irilmi\u015f n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcdd\u0259t otaq temperaturunda saxlan\u0131lmas\u0131<\/p>\n

Referens:<\/strong>\u00a0Neqativ<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0Toxoplasma gondii ibti\u00addail\u0259rin\u0259\u00a0<\/em>aid B1 geninin PZR il\u0259 t\u0259\u00adyini prenatal toksoplazma infek\u00adsi\u00adyas\u0131n\u0131n diaqnozuna k\u00f6m\u0259k edir. \u0130mmun \u00e7at\u0131\u015fmazl\u0131\u011f\u0131 olan x\u0259st\u0259l\u0259rd\u0259 (Q\u0130\u00c7S v\u0259 s.) d\u0259 bu \u00fcsul istifad\u0259 oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

V\u018fR\u018fM\u0130N MOLEKULYAR D\u0130AQNOZU<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:<\/strong>\u00a0Tbc DNT; Tbc PCR; Gen-probe MTD<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>\u00a0B\u0259l\u011f\u0259m, bronxoal\u00adveolyar lavaj mayesi, m\u0259d\u0259 \u015fir\u0259si, sidik, BOM, plevra, perikard, assit v\u0259 oynaq mayesi kimi orqanizm mayel\u0259ri, toxuma n\u00fcmun\u0259l\u0259ri, abses (qan v\u0259 qanl\u0131 n\u00fcmun\u0259l\u0259r il\u0259 m\u00fcayin\u0259 apar\u0131lm\u0131r)<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Steril, bur\u011fulu qapaql\u0131 qab<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0B\u0259l\u011f\u0259m (10 mL), sidik (2 mL), orqanizm mayel\u0259ri (10-15 mL), BOM (2 mL)<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>Mycobacterium kulturas\u0131 \u00fc\u00e7\u00fcn t\u0259yin olunmu\u015f n\u00fcmun\u0259 alma qaydalar\u0131 q\u00fcvv\u0259d\u0259dir. Qanl\u0131 v\u0259 parafinli biopsiya n\u00fcmun\u0259sind\u0259n m\u00fcayin\u0259 \u00fc\u00e7\u00fcn istifad\u0259 etm\u0259k olmaz<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0Trasnscription Mediated Amplification (TMA)<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0N\u00fc\u00admun\u0259 miqdar\u0131n\u0131n yet\u0259rli olmamas\u0131, steril qabada al\u0131nmamas\u0131, b\u0259l\u011f\u0259m yerin\u0259 a\u011f\u0131z suyu verilm\u0259si, n\u00fcmu\u00adn\u0259nin qanl\u0131 olmas\u0131<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0N\u00fcmun\u0259d\u0259\u00a0M.Tuber\u00adculosis\u00a0<\/em>varl\u0131\u011f\u0131n\u0131 d\u0259qiql\u0259\u015fdirm\u0259k \u00fc\u00e7\u00fcn istifad\u0259 olunur. Bu \u00fcsulla, n\u00fc\u00admun\u0259d\u0259 1 v\u0259r\u0259m \u00e7\u00f6p\u00fc\/mL ol\u00adduqda bel\u0259 diaqnoz qoyula bilir. S\u00fcr\u0259tli diaq\u00adnoza imkan verm\u0259si \u00fcst\u00fcn c\u0259h\u0259tidir<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

ERK\u018fN MOLEKULYAR D\u0130AQNOZ TEST\u0130<\/a><\/h2>\r\n
\r\n
\r\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Amnion mayesi, g\u00f6b\u0259k ciy\u0259sind\u0259n al\u0131nm\u0131\u015f qan<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0B\u0259n\u00f6v\u015f\u0259yi qapaql\u0131 (EDTA-l\u0131) s\u0131naq \u015f\u00fc\u015f\u0259si (g\u00f6b\u0259k ciy\u0259\u00adsind\u0259n al\u0131nm\u0131\u015f qan)<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:<\/strong>\u00a0Amnion mayesi (2mL), g\u00f6b\u0259k ciy\u0259sind\u0259n al\u0131nm\u0131\u015f qan (1 mL)<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131:\u00a0<\/strong>N\u00fc\u00admu\u00adn\u0259 al\u0131nmazdan \u0259vv\u0259l laboratoriya il\u0259 \u0259laq\u0259 saxlan\u0131lmal\u0131d\u0131r. N\u00fcmun\u0259 24 saat \u0259rzind\u0259 laboratoriyaya \u00e7atd\u0131r\u0131l\u00admal\u0131d\u0131r<\/p>\n

X\u0259st\u0259nin haz\u0131rlanmas\u0131:<\/strong>\u00a0X\u00fcsusi an\u00adket formas\u0131n\u0131n doldurulmas\u0131 vacib\u00addir. Bu forman\u0131n tam v\u0259 d\u00fczg\u00fcn \u015f\u0259\u00adkild\u0259 doldurulmas\u0131 apar\u0131lacaq mole\u00adkulyar analizin d\u00fcr\u00fcstl\u00fcy\u00fc bax\u0131\u00adm\u0131n\u00addan \u00e7ox \u0259h\u0259miyy\u0259tlidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0QF-PZR<\/p>\n

\u0130stifad\u0259si:<\/strong>\u00a0Kariyotipl\u0259ndirm\u0259d\u0259n \u0259v\u00adv\u0259l \u0259hali aras\u0131nda \u00e7ox rast g\u0259lin\u0259n 13, 18, 21 v\u0259 cinsiyy\u0259t xromo\u00adsom\u00adla\u00adr\u0131\u00adna aid anoploidl\u0259rin 24-48 saat m\u00fcd\u00add\u0259tind\u0259 skrininqind\u0259 istifad\u0259 olu\u00ad\u00adnur. \u018fld\u0259 olunmu\u015f m\u0259lumatlar sito\u00adgenetik analizl\u0259rl\u0259 d\u0259qiql\u0259\u015fdiril\u00adm\u0259lidir<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section>

\r\n

HEPAT\u0130T B DNT (HBV DNT)<\/a><\/h2>\r\n
\r\n
\r\n

Sinonim:\u00a0<\/strong>Hepatit B DNT<\/p>\n

N\u00fcmun\u0259 n\u00f6v\u00fc:\u00a0<\/strong>Serum<\/p>\n

N\u00fcmun\u0259 qab\u0131:<\/strong>\u00a0Q\u0131rm\u0131z\u0131 qapaql\u0131 s\u0131naq \u015f\u00fc\u015f\u0259si<\/p>\n

N\u00fcmun\u0259 miqdar\u0131:\u00a0<\/strong>500 \u03bcL<\/p>\n

N\u00fcmun\u0259nin al\u0131nma qaydas\u0131 :\u00a0<\/strong>N\u00fc\u00admun\u0259 soyuq \u015f\u0259raitd\u0259 saxlanmal\u0131 v\u0259 laboratoriyaya g\u00f6nd\u0259rilm\u0259lidir<\/p>\n

\u0130\u015f prinsipi:<\/strong>\u00a0PZR<\/p>\n

N\u00fcmun\u0259d\u0259n imtina s\u0259b\u0259bl\u0259ri:<\/strong>\u00a0He\u00admolizli, EDTA-l\u0131 v\u0259 ya heparinli n\u00fcmun\u0259l\u0259r v\u0259 n\u00fcmun\u0259nin uzun m\u00fcd\u00add\u0259t otaq temperaturunda qalmas\u0131<\/p>\n

Referens:\u00a0<\/strong>Neqativ<\/p>\n

\u0130stifad\u0259si:\u00a0<\/strong>HBV infeksiyalar\u0131n\u0131n er\u00adk\u0259n d\u00f6vrl\u0259rind\u0259 ancisim s\u0259viyy\u0259si a\u015fa\u00ad\u011f\u0131 oldu\u011fundan seroloji testl\u0259r ye\u00adt\u0259rsizdir. Bu s\u0259b\u0259bd\u0259n virusun bir\u00adba\u015fa t\u0259yinin\u0259 imkan ver\u0259n h\u0259ssas v\u0259 spesifik PZR \u00fcsulu istifad\u0259 olunur. Asimptomatik da\u015f\u0131y\u0131c\u0131lar, anticisim \u0259m\u0259l\u0259 g\u0259l\u0259n\u0259 q\u0259d\u0259rki m\u0259rh\u0259l\u0259, sero\u00adpozitiv analardan do\u011fulan u\u015faqlar, immunoloji reaksiya verm\u0259y\u0259n x\u0259s\u00adt\u0259l\u0259r, h\u0259m\u00e7inin seroloji testl\u0259ri po\u00adzi\u00adtiv olan x\u0259st\u0259l\u0259rd\u0259 diaq\u00adnozun d\u0259qiq\u00adl\u0259\u015fdirilm\u0259si v\u0259 m\u00fcalic\u0259nin m\u00fc\u015fa\u00adhi\u00add\u0259si \u00fc\u00e7\u00fcn HBV DNT istifad\u0259 oluna bil\u0259r<\/p>\n\r\n <\/div>\r\n <\/div>\r\n <\/section><\/div>[\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-15884","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/pages\/15884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/comments?post=15884"}],"version-history":[{"count":2,"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/pages\/15884\/revisions"}],"predecessor-version":[{"id":15922,"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/pages\/15884\/revisions\/15922"}],"wp:attachment":[{"href":"https:\/\/incilab.az\/en\/wp-json\/wp\/v2\/media?parent=15884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}